Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design

首次发布于 2009 年 11 月 25 日

Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer

计划入组 3 人 · 首次发布于 2013 年 8 月 23 日

Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)

计划入组 15 人 · 首次发布于 2008 年 4 月 11 日

Hyaluronidase (human recombinant)(Darzalex Faspro, Herceptin Hylecta, Hylenex, Hyqvia 5 G / 50 Ml Kit, Phesgo, Rituxan Hycela, Vyvgart Hytrulo)

Recombinant human hyaluronidase/bisphosphonates(Halozyme Therapeutics, Inc.)

Recombinant human hyaluronidase-based subcutaneous therapeutic (Roche)

EicOsis Human Health, Inc.

United States

ABLE HUMAN MOTION S.L.

Spain

Center For Human Reproduction

United States

Huonslab Submits Biologics License Application for Recombinant Human Hyaluronidase HYDIZYME™

Subcutaneous Immunoglobulin with Hyaluronidase Shows Promise for Idiopathic Inflammatory Myositis Treatment

Huonslab Secures Key Patent for Albumin-Free Hyaluronidase Formulation, Advances Toward 2026 Market Authorization